Amid ongoing geopolitical complexities and “profound transformations” affecting the pharmaceutical industry, French authorities and pharmaceutical industry representatives have signed an agreement on a new drug pricing framework.
Amid ongoing geopolitical complexities and “profound transformations” affecting the pharmaceutical industry, French authorities and pharmaceutical industry representatives have signed an agreement on a new drug pricing framework.